Publications by authors named "Precious Radebe"
Article Synopsis
- - In South Africa, a study focused on women living with HIV (WLHIV) found a high prevalence of high-risk HPV infections, with 67.3% testing positive, particularly HPV16 and HPV18/45 types being common.
- - Many participants (91.3%) had never been screened for cervical cancer, and a significant portion (33.3%) showed abnormal cervical cytology results, strongly correlating this with HPV positivity.
- - The research emphasizes the importance of early HIV diagnosis and treatment, as well as regular cervical cancer screenings, particularly for those with low CD4 cell counts, to reduce cervical cancer risks among WLHIV.
Introduction: Women-controlled HIV prevention technologies that overcome adherence challenges of available daily oral pre-exposure prophylaxis and give women a choice of options are urgently needed. Broadly neutralising monoclonal antibodies (bnAbs) administered passively may offer a valuable non-antiretroviral biological intervention for HIV prevention. Animal and human studies have demonstrated that bnAbs which neutralise HIV can prevent infection.
View Article and Find Full Text PDFCAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.
BMJ Open
January 2022
Introduction: Young African women bear a disproportionately high risk for HIV acquisition. HIV technologies that empower women to protect themselves are needed. Safe, potent antiretroviral agents such as tenofovir alafenamide (TAF), formulated as long-acting subdermal implants, offer an innovative solution.
View Article and Find Full Text PDF